美國人工心臟瓣膜市場：2011年

美國人工心臟瓣膜市場：2011年 是由出版商Millennium Research Group在2011年06月所出版的。 這份英文市場調查報告書價格從美金5995起跳。

簡介

美國人工心臟瓣膜市場預計2015年止，因經導管心臟瓣膜（THV）之發表而快速發展，將創極佳紀錄。此外，因THV設備平均售價高，將可成為收益之強大支援。

本報告為，提供美國人工心臟瓣膜市場於臨床環境及各種心臟瓣膜市場之趨勢、競合環境、未來市場展望等調查結果，以下列摘要形式闡述。

實施概要

第1章 臨床環境

• 適應症
  • 簡介
  • 心臟瓣膜疾病
• 診斷及照會型態
• 處理概要
  • 心臟瓣膜處理
    • 心臟瓣膜置換手術
    • 心臟瓣膜修復手術
    • 經導管心臟瓣膜治療
  • 競合治療
• 索引

第2章 設備

• 概要
  • 調查設備
  • 特性
• 生物瓣
  • 功能
  • 特性
  • 已知適應症
• 機械瓣市場
  • 功能
  • 已知適應症
• 瓣環形成設備
  • 功能
  • 臨床證據
  • 已知適應症
• 經導管心臟瓣膜設備
  • 功能

第3章 品牌及競合分析

• 概要
  • 競合分析
  • 詳細競合情勢
  • 市場佔有率
  • 近來事件
• 生物瓣市場
  • 競合分析
  • 詳細競合情勢
  • 領導企業
  • 目前市場佔有率
• 機械瓣市場
  • 競合分析
  • 詳細競合情勢
  • 領導企業
  • 目前市場佔有率
  • 目前進行之臨床實驗
• 瓣環形成設備
  • 競合分析
  • 詳細競合情勢
  • 領導企業
  • 目前市場佔有率
• 經導管心臟瓣膜設備
  • 競合分析
  • 詳細競合情勢

第4章 目前進行之臨床實驗及新產品

• 目前進行之臨床實驗
  • 機械瓣市場
  • 經導管主動脈瓣置換設備市場
  • 經皮二尖瓣修復設備市場
• 新產品
• 生物瓣市場
• 瓣環形成設備市場
• 經導管心臟瓣膜設備市場

第5章 市場展望

• 概要
• 生物瓣市場
  • 市場評估
  • 詳細市場概要
• 機械瓣市場
  • 市場評估
  • 詳細市場概要
• 瓣環形成設備市場
  • 市場評估
  • 詳細市場概要
• 經導管心臟瓣膜設備市場
  • 市場評估
  • 詳細市場概要

附錄

目錄

Abstract

The US heart valve device market will experience strong growth through 2015, driven primarily by the introduction of transcatheter heart valve (THV) devices and their rapid adoption. Revenue expansion will be supported by the high average selling price (ASP) of THV devices, although this will occur at the expense of other technologies; while tissue heart valve and annuloplasty procedure volumes will continue to rise gradually over the forecast period, they will face increasing competition from THV devices. ASP growth in this market will also be fueled by rising cardiac surgeon preference for more expensive tissue heart valves - which offer improved biocompatibility and superior hemodynamic characteristics - over less costly mechanical ones. Cost reduction pressures on health care facilities following the economic recession will, however, push market players to increasingly compete on price, curbing ASP growth somewhat.

Companies mentioned in this report:

• Abbott Vascular
• Advanced Bio Prosthetic Surfaces
• AorTx (acquired by Hansen Medical)
• Boston Scientific
• Cardiac Dimensions
• CardiAQ Valve Technologies
• Cardiosolutions
• CryoLife
• Direct Flow Medical
• Edwards Lifesciences
• Endoluminal Technology Research
• Endovalve
• Guided Delivery Systems
• Hansen Medical
• Heart Leaflet Technologies (acquired by The Bracco Group)
• JenaValve Technology
• LifeNet Health
• Mardil Medical
• Medtronic
• MiCardia
• Mitralign
• NeoChord
• Northwest Tissue Services
• On-X Life Technologies
• QuantumCor
• Sorin Group
• St. Jude Medical
• Symetis
• The Bracco Group
• ValveXchange

RESEARCH METHODOLOGY

This report uses a number of methodologies to gather and present data and analysis. At the outset, a large survey of secondary sources is conducted. These sources act as the basis for the primary research stage, which builds and enhances the quantitative and qualitative attributes of the early research.

• Government sources:
  • Securities and Exchange Commission filings
  • Food and Drug Administration and patent filings
  • National Center for Health Statistics data
  • U.S. Census Bureau
• Heart valve device companies companies:
  • Annual reports, product brochures, corporate profiles, etc.
• Internal databases and reports:
  • Previous reports on similar/related sources
• General Internet searches, medical literature, and newspaper/magazine searches:
  • Identifying various centers of specialization and articles that might provide leads for primary research

The secondary research stage builds the foundation for the primary research.

Step 1: The first step involves an impartial scan of all the information gathered during the secondary research stage to determine its utility based on the specific requirements of this report. Each piece of information is either discarded or marked as high- or low-priority and then organized appropriately as determined by the structure and sectioning of the report.

Step 2: At this stage, early assumptions are formed as to the implications of the information for the various heart valve device market segments. These assumptions are then used to determine hypotheses using both inductive and deductive approaches. On the quantitative front, these hypotheses result in full historical and projected market data sets (market sizes - unit sales, average selling prices [ASPs], and revenues - as well as market shares).

Step 3: At this stage, the research is in position for its most important primary phase - expert interviews. Throughout the secondary research phase, industry and medical experts are identified.

These experts are then contacted by telephone and asked to participate in interviews on recent trends and developments in the industry. Interviews are either conducted at the time of the initial call or scheduled at the convenience of the expert. Interview questions are tailored to the expertise of each particular interviewee, although in most cases, the most important questions are asked of all experts.

The questions are largely based on the assumptions and hypotheses developed in Step 2, which are then augmented, discarded, or adjusted based on the views and positions put forth. Attempts are made, whenever possible, to cross-check the views of various experts against each other and to reach positions of consensus on issues and market numbers.

In addition, a sample of relevant physicians is interviewed. Physicians are asked to comment on various issues/trends, both in their own practice and in the overall market. The responses provided are then used to strengthen or augment the assumptions and hypotheses developed during the primary research phase.

Step 4: The final stage of primary research involves individual and group analysis by Millennium Research Group. All research results are assessed and cross-checked thoroughly to determine their validity, relevance, and weight. From this process, qualitative conclusions are reached and data points finalized.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

1.0 CLINICAL LANDSCAPE

• 1.1. Indications
  • 1.1.1. Introduction
  • 1.1.2. Heart Valve Disease
• 1.2. Diagnosis and Referral Patterns
• 1.3. Procedure Overview
  • 1.3.1. Heart Valve Procedures
    • 1.3.1.1. Surgical Heart Valve Replacement
    • 1.3.1.2. Surgical Heart Valve Repair
    • 1.3.1.3. Transcatheter Heart Valve Treatment
  • 1.3.2. Competing Treatments
    • 1.3.2.1. Heart Valve Disease Medical Management
    • 1.3.2.2. Balloon Valvuloplasty
    • 1.3.2.3. Aortic Valve Bypass
• 1.4. Guidelines

2.0 DEVICES

• 2.1. Overview
  • 2.1.1. Devices Covered
  • 2.1.2. Differentiating Features
• 2.2. Tissue Replacement Valves
  • 2.2.1. Functions
  • 2.2.2. Differentiating Features
  • 2.2.3. Labeled Indications
• 2.3. Mechanical Heart Valves
  • 2.3.1. Functions
  • 2.3.2. Labeled Indications
• 2.4. Annuloplasty Devices
  • 2.4.1. Functions
  • 2.4.2. Clinical Evidence
  • 2.4.3. Labeled Indications
• 2.5. Transcatheter Heart Valve Devices
  • 2.5.1. Functions
    • 2.5.1.1. Transcatheter Aortic Valve Replacement Devices
    • 2.5.1.2. Transcatheter Mitral Valve Repair Devices

3.0 BRANDS AND COMPETITIVE ANALYSIS

• 3.1. Overview
  • 3.1.1. Competitive Snapshot
  • 3.1.2. Detailed Competitive Landscape
  • 3.1.3. Market Shares
  • 3.1.4. Recent Events
• 3.2. Tissue Heart Valve Market
  • 3.2.1. Competitive Snapshot
  • 3.2.2. Detailed Competitive Landscape
  • 3.2.3. Leading Competitors
  • 3.2.4. Current Market Shares
• 3.3. Mechanical Heart Valve Market
  • 3.3.1. Competitive Snapshot
  • 3.3.2. Detailed Competitive Landscape
  • 3.3.3. Leading Competitors
  • 3.3.4. Current Market Shares
  • 3.3.5. Ongoing Head-to-Head Clinical Trials
• 3.4. Annuloplasty Device Market
  • 3.4.1. Competitive Snapshot
  • 3.4.2. Detailed Competitive Landscape
  • 3.4.3. Leading Competitors
  • 3.4.4. Current Market Shares
• 3.5. Transcatheter Heart Valve Device Market
  • 3.5.1. Competitive Snapshot
  • 3.5.2. Detailed Competitive Landscape

4.0 ONGOING CLINICAL TRIALS AND EMERGING PRODUCTS

• 4.1. Ongoing Clinical Trials
  • 4.1.1. Mechanical Heart Valve Market
  • 4.1.2. Transcatheter Aortic Valve Replacement Device Market
  • 4.1.3. Percutaneous Mitral Valve Repair Device Market
• 4.2. Emerging Products
  • 4.2.1. Tissue Heart Valve Market
  • 4.2.2. Annuloplasty Device Market
  • 4.2.3. Transcatheter Heart Valve Device Market
    • 4.2.3.1. Transcatheter Aortic Valve Replacement Devices
    • 4.2.3.2. Percutaneous Mitral Valve Repair Devices
    • 4.2.3.3. Transcatheter Mitral Valve Replacement Devices
    • 4.2.3.4. Transcatheter Pulmonary Valve Replacement Devices

5.0 MARKET OUTLOOK

• 5.1. Overview
  • 5.1.1. Market Snapshot
  • 5.1.2. Detailed Market Overview
• 5.2. Tissue Heart Valve Market
  • 5.2.1. Market Snapshot
  • 5.2.2. Detailed Market Overview
• 5.3. Mechanical Heart Valve Market
  • 5.3.1. Market Snapshot
  • 5.3.2. Detailed Market Overview
• 5.4. Annuloplasty Device Market
  • 5.4.1. Market Snapshot
  • 5.4.2. Detailed Market Overview
• 5.5. Transcatheter Heart Valve Device Market
  • 5.5.1. Market Snapshot
  • 5.5.2. Detailed Market Overview

APPENDIX A: METHODOLOGY

APPENDIX B: MRG ACRONYMS AND INITIALISMS

APPENDIX C: BIBLIOGRAPHY

APPENDIX D: SUPPLEMENTAL FIGURES

LIST OF FIGURES AND TABLES

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

• Figure 1: Heart Valve Device Market, by Product Type, US (US$), 2009 - 2015
• Table 1: Heart Valve Device Market Landscape, US (US$), 2010 and 2015
• Table 2: Heart Valve Device Market Leaders, by Product Type and Revenue, US, 2010
• Table 3: Most Promising Emerging Technologies in the Heart Valve Device Market, US, 2011 - 2015
• Table 4: Factors Impacting the US Heart Valve Device Market, by Product Type, 2010 - 2015
• Table 5: Key Report Updates, 2011

1.0 CLINICAL LANDSCAPE

• Figure 2: Treatment Providers and Referral Patterns, US
• Table 6: Treatment Providers and Referral Patterns, by Treatment Phase, US
• Table 7: Heart Valve Device Procedures, US
• Table 8: Competing Treatments, US

2.0 DEVICES

• Table 9: US Heart Valve Device Market, by Product Type
• Figure 3: Recommendations for Heart Valve Devices, by Age Group, US
• Table 10: Advantages and Disadvantages of Heart Valve Devices, by Product Type
• Table 11: Tissue Heart Valve Functions, by Material Group and Product Features
• Table 12: Advantages and Disadvantages of Tissue Heart Valves, by Material Group
• Table 13: Advantages and Disadvantages of Xenograft Tissue Heart Valves, by Product Feature
• Table 14: Advantages and Disadvantages of Xenograft Tissue Heart Valves, by Material
• Table 15: Summary of Porcine Tissue Valve Long-Term Durability Trial
• Table 16: Summary of Pericardial Tissue Valve Long-Term Durability Trial
• Table 17: Summary of Mitral Valve Repair versus Mitral Valve Replacement Trial
• Table 18: Summary of Mitral Valve Repair Long-Term Safety and Efficacy Trial

3.0 BRANDS AND COMPETITIVE ANALYSIS

• Table 19: Leading Competitors in the Heart Valve Device Market, by Product Type, as a % of Total, US, 2010
• Table 20: Recent Clinical Milestones in the THV Device Market, US, 2011
• Table 21: Recent Events in the Heart Valve Device Market, US, 2011
• Table 22: Leading Competitors and Brands in the Tissue Heart Valve Market, US (US$), 2010
• Table 23: Leading Competitors in the Tissue Heart Valve Market, by Material Group, as % of Total, US, 2010
• Table 24: Leading Competitors and Brands in the Mechanical Heart Valve Market, US, 2010
• Table 25: Leading Competitors in the Mechanical Heart Valve Market, as a % of Total, US, 2010
• Table 26: Summary of PROSE
• Table 27: Leading Competitors and Brands in the Annuloplasty Device Market, US (US$), 2010
• Table 28: Leading Competitors in the Annuloplasty Device Market, as a % of Total, US, 2010

4.0 ONGOING CLINICAL TRIALS AND EMERGING PRODUCTS

• Table 29: Summary of PROACT
• Table 30: Summary of PARTNER
• Table 31: Summary of PARTNER II
• Table 32: Summary of Medtronic CoreValve U.S. Pivotal Trial
• Table 33: Summary of Medtronic CoreValve REDO Study
• Table 34: Summary of EVEREST II
• Table 35: Emerging Technologies in Development for the Tissue Heart Valve Market, US, 2011 - 2015
• Table 36: Emerging Technologies in the TAVR Device Market, US, 2011 - 2015
• Table 37: Emerging Technologies in Development in the TMVR Device Market, US, 2011 - 2015

5.0 MARKET OUTLOOK

• Figure 4: Heart Valve Device Market, by Product Type, as a % of Total, US, 2010 and 2015
• Table 38: Factors Impacting the Heart Valve Device Market, by Product Type, US, 2010 - 2015
• Table 39: Heart Valve Device Procedures, by Position, US, 2009 - 2015
• Table 40: Heart Valve Device Procedures, by Product Type, US, 2009 - 2015
• Table 41: Heart Valve Device Market, by Product Type, US (US$), 2009 - 2015
• Table 42: Heart Valve Device Market Growth, by Product Type, US, 2010 - 2015
• Table 43: Heart Valve Device Market, by Product Type, as a % of Total, US, 2009 - 2015
• Table 44: Aortic Heart Valve Replacements, by Product Type, US, 2009 - 2015
• Table 45: Aortic Heart Valve Replacement Market, by Product Type, US (US$), 2009 - 2015
• Table 46: Aortic Heart Valve Replacement Market Growth, by Product Type, US, 2010 - 2015
• Table 47: Aortic Heart Valve Replacement Market, by Product Type, as a % of Total, US, 2009 - 2015
• Table 48: Mitral Valve Repairs, by Product Type, US, 2009 - 2015
• Table 49: Mitral Heart Valve Repair Market, by Product Type, US (US$), 2009 - 2015
• Table 50: Mitral Valve Repair Market Growth, by Product Type, US, 2010 - 2015
• Table 51: Mitral Valve Repair Market, by Product Type, as a % of Total, US, 2009 - 2015
• Figure 5: Tissue Heart Valve Market, by Material Group, US (US$), 2009 - 2015
• Table 52: Tissue Heart Valve Procedures, by Material Group, US, 2009 - 2015
• Table 53: Tissue Heart Valve Procedures, by Position, US, 2009 - 2015
• Table 54: Xenograft Tissue Heart Valve Procedures, by Product Feature, US, 2009 - 2015
• Table 55: Tissue Heart Valve Market, by Material Group, US (US$), 2009 - 2015
• Table 56: Tissue Heart Valve Market Growth, by Material Group, US, 2010 - 2015
• Table 57: Tissue Heart Valve Market, by Material Group, as a % of Total, US, 2009 - 2015
• Table 58: Xenograft Tissue Heart Valve Market, by Product Feature, US (US$), 2009 - 2015
• Table 59: Xenograft Tissue Heart Valve Market Growth, by Product Feature, US, 2010 - 2015
• Table 60: Xenograft Tissue Heart Valve Market, by Product Feature, as a % of Total, US, 2009 - 2015
• Figure 6: Mechanical Heart Valve Market, US (US$), 2009 - 2015
• Table 61: Mechanical Heart Valve Procedures, by Position, US, 2009 - 2015
• Table 62: Mechanical Heart Valve Market, US (US$), 2009 - 2015
• Figure 7: Annuloplasty Device Market, US (US$), 2009 - 2015
• Table 63: Annuloplasty Device Procedures, by Shape, US, 2009 - 2015
• Table 64: Annuloplasty Device Procedures, by Position, US, 2009 - 2015
• Table 65: Annuloplasty Device Market, by Shape, US (US$), 2009 - 2015
• Table 66: Annuloplasty Device Market Growth, by Shape, US, 2010 - 2015
• Table 67: Annuloplasty Device Market, by Shape, as a % of Total, US, 2009 - 2015
• Figure 8: THV Device Procedures, by Product Type, US, 2009 - 2015
• Table 68: THV Device Procedures, by Product Type, US, 2009 - 2015
• Table 69: THV Device Market, by Product Type, US (US$), 2009 - 2015
• Table 70: THV Device Market Growth, by Product Type, US, 2012 - 2015
• Table 71: THV Device Market, by Product Type, as a % of Total, US, 2011 - 2015

APPENDIX A: METHODOLOGY

• Table 72: ICD-9-CM Procedure Codes and Descriptions

APPENDIX B: MRG ACRONYMS AND INITIALISMS

• MRG Acronyms and Initialisms

APPENDIX C: BIBLIOGRAPHY

APPENDIX D: SUPPLEMENTAL FIGURES

• Figure 9: Heart Valve Device Market, by Product Type, US (US$), 2009 - 2015 (Detailed Format)

相關商品

心血管設備相關市場調查報告書

全球心臟輔助設備市場：2011年∼2015年
Global Cardiac Assist Device Market 2011-2015
價格 : US $ 1500
出版日期 : 2012年05月

全球人工輔助心臟（VAD）市場：2011年∼2015年
Global Ventricular Assist Device Market 2011-2015
價格 : US $ 1500
出版日期 : 2012年04月

全球植入式心臟整流去顫器（ICD）市場：2011年∼2015年
Global Implantable Cardioverter Defibrillators Market 2011-2015
價格 : US $ 1500
出版日期 : 2012年04月

Millennium Research Group發行的醫療設備相關市場調查報告書

歐洲的重病患者管理用資訊系統市場:2012年

European Markets for High-Acuity Information Systems 2012

價格 : US $ 5995

出版日期 : 2012年04月

亞太地區的經導管栓塞·阻塞設備市場:2012年

Asia Pacific Markets for Transcatheter Embolization and Occlusion Devices 2012

價格 : US $ 6995

出版日期 : 2012年04月

歐洲的整形外科用軟組織解決方案市場:2012年

European Markets for Orthopedic Soft Tissue Solutions 2012

價格 : US $ 5995

出版日期 : 2012年03月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!